$MRSH

MRSH Maintained by Citigroup -- Price Target Raised to $203

Citigroup maintained a Neutral rating on Marsh (MRSH) and raised its price target from $200 to $203. Marsh is trading at $188.35, which is 26.2% undervalued compared to its GF Value™ of $255.35. The company has a GF Score™ of 84/100, reflecting strong profitability and growth. 13 gurus hold MRSH, with mixed activity in recent quarters.

Original reporting
Published Oct 16, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$MRSH
Neutral
medium confidence
Mentioned
$MRSH
Relevance
5/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$MRSHNeutralLow
01

Why it matters

The rating maintenance and modest target raise provide a small catalyst but do not constitute a major shift in outlook.

02

Market read

Limited relevance; primarily of interest to existing shareholders and value‑oriented traders.

03

What to watch

Insider selling of $8.2 M in shares could weigh on sentiment despite the higher target.

Relevance 5/10Novelty 4/10Timing: today

Background

Marsh is a large insurance brokerage with a market cap of ~$90 B. The analyst note highlights valuation metrics and guru activity.

Company-level read

Ticker impact

$MRSHNeutralMedium confidence
Context

Citigroup maintained a Neutral rating on Marsh and raised its price target to $203, up from $200, indicating modest optimism.

Expected impact

likely mild upward pressure as investors price in the higher target

Evidence & confidence

A small target raise without a rating upgrade suggests limited catalyst strength; price may inch higher but not a strong move.

Market effects

The update reinforces a neutral stance on the insurance brokerage sector, with limited impact on peers.

US market focus; no broader regional effect.

Minimal; the news is company‑specific.

Counterpoint

Investors could view the unchanged rating as a sign that the stock is fairly valued and may not rally further.

Key entities

  • Citigroup

    Maintained Neutral rating and raised price target.

  • Marsh (MRSH)

    Insurance brokerage subject of the rating update.

Related articles

$MRSHMedAI 8/10

Why Marsh (MRSH) Stock Is Trading Up Today

Marsh (MRSH) shares rose 4.7% after reporting Q3 2026 results with 8% revenue growth and 10% increase in adjusted EPS. GAAP earnings were $1.69, adjusted earnings $2.03. The company repurchased $500M in stock and raised its savings target to $600M. Shares closed at $186.43, up 4.5%.

$MRSHHighAI 8/10

Marsh McLennan earnings analysis: questions answered and next catalysts

Marsh McLennan (MRSH) reported Q3 FY2026 earnings on Oct 15, 2026, beating estimates with EPS of $2.03 and revenue of $6.86B. The stock rose 5.49% to $188.19. Analysts had lowered price targets before the report, contributing to the rally. Key questions remain about organic growth durability and valuation. Next catalysts include Q4 earnings, 2027 guidance, and analyst revisions.

$MRSHHighAI 8/10

Marsh McLennan (MRSH) Q3 2026 Earnings Call Transcript

Marsh McLennan (MRSH) reported Q3 2026 earnings with revenue up 8%, adjusted operating income up 6%, and adjusted EPS up 10%. The company highlighted growth in consulting and risk services, increased Thrive savings target to $600M, and progress in AI integration. They also repurchased $500M in stock. Market conditions showed mixed rate changes across regions and lines of business.